In the article ‘Comparative sensitivity evaluation for 122 CE-marked rapid diagnostic tests for SARS-CoV-2 antigen, Germany, September 2020 to April 2021’ by Scheiblauer et al., published on 4 November 2021, a footnote was added in Table 2 further explaining the reason for the results (originally labelled as 0% sensitivity) obtained for tests 107 and 109 which showed false-positive background activity to all panel samples and to all negative controls, in contrast to the negative results obtained for tests 99 and 118. These changes were made on request of the authors on 22 January 2022.
. 2022 Jan 20;27(3):210120c. doi: 10.2807/1560-7917.ES.2021.27.3.210120c
Author's correction for Euro Surveill. 2021;26(44)
Eurosurveillance editorial team1
1European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden
Correspondence: Eurosurveillance editorial team (eurosurveillance@ecdc.europa.eu)
This article is copyright of the authors or their affiliated institutions, 2022.
This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.
PMCID: PMC8804667 PMID: 35057898
This corrects the article "Comparative sensitivity evaluation for 122 CE-marked rapid diagnostic tests for SARS-CoV-2 antigen, Germany, September 2020 to April 2021" in volume 26, 2100441.